Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
schizophrenia drug
Pharma
Teva looks to peel back the onion on mental health: exec
The company is currently studying a long-acting version of olanzapine, an aging schizophrenia treatment that Eli Lilly markets as Zyprexa.
Zoey Becker
Dec 31, 2024 8:00am
Intra-Cellular's unstoppable Caplyta nails another trial
Nov 5, 2024 10:15am
As new drugs deliver, BMS explores further efficiency moves
Oct 31, 2024 10:27am
BMS wins FDA approval for new schizophrenia med Cobenfy
Sep 26, 2024 7:38pm
BMS taps Taye Diggs for schizophrenia educational campaign
May 22, 2024 3:10pm
Top 10 most anticipated drug launches of 2024
Jan 29, 2024 6:00am
